Naphthyl-substituted and anilide-substituted sulfonamides

US6417181B1 · kind B1 · utility

Assignee

• BAYER HEALTHCARE LLC · DE

Inventors

• Wolfgang Bender · Wuppertal, DE
• Jurgen Reefschlager · Oldenburg, DE
• Peter Eckenberg · Wuppertal, DE
• Siegfried Goldmann · Wuppertal, DE
• Michael Härter · Wixom, US
• Sabine Hallenberger · Wuppertal, DE
• Jörg Trappe · Monza, IT
• Olaf Weber · Wülfrath, DE

Key dates

• Filing date: Sep 1, 2000
• Grant date: Jul 9, 2002
• Expiry date: Sep 1, 2020

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02P20/55
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present invention relates to new naphthyl- and anilide-substituted sulphonamides of the general formula (I) in which the substituents A, D, E, G, R1, R2, R3, R4 and X have the meanings indicated,and to processes for their preparation and their use as antiviral agents, in particular against cytomegaloviruses.